Bought at 5.04. Analysts have it at 10. Down for a minor FDA issue. If it blows over, should be able to double the money in 24 months.Cheap, Lazy Reference links: Yahoo! Finance, Wall Street Survivor, Motley Fool CAPS, TheStreet, Google Finance, MSN Money
Spectrum Pharmaceuticals, Inc. (SPPI)
You must be logged in to post a comment.